ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 68 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,851,578 | -62.8% | 1,178,338 | -37.8% | 0.03% | -47.7% |
| Q1 2024 | $7,674,843 | +5.5% | 1,895,023 | 0.0% | 0.06% | +4.8% |
| Q4 2023 | $7,276,888 | -7.5% | 1,895,023 | 0.0% | 0.06% | +29.2% |
| Q3 2023 | $7,864,345 | +35.5% | 1,895,023 | +57.1% | 0.05% | +50.0% |
| Q2 2023 | $5,803,496 | +18.5% | 1,206,548 | 0.0% | 0.03% | -3.0% |
| Q1 2023 | $4,898,585 | -24.8% | 1,206,548 | 0.0% | 0.03% | +10.0% |
| Q4 2022 | $6,515,359 | -46.2% | 1,206,548 | 0.0% | 0.03% | -57.7% |
| Q3 2022 | $12,101,000 | +113.4% | 1,206,548 | 0.0% | 0.07% | -19.3% |
| Q2 2022 | $5,671,000 | +120.8% | 1,206,548 | +83.7% | 0.09% | +183.9% |
| Q1 2022 | $2,568,000 | -42.2% | 656,848 | 0.0% | 0.03% | -31.1% |
| Q4 2021 | $4,440,000 | -54.5% | 656,848 | 0.0% | 0.04% | +9.8% |
| Q3 2021 | $9,761,000 | – | 656,848 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $8,269,322 | 2.77% |
| RA Capital Management | 14,932,063 | $36,135,592 | 0.48% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $3,940,994 | 0.44% |
| Rock Springs Capital Management LP | 2,300,059 | $5,566,143 | 0.17% |
| Ikarian Capital, LLC | 266,435 | $644,774 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 89,699 | $217,072 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 15,304 | $37,036 | 0.04% |
| Laurion Capital Management LP | 1,178,338 | $2,851,578 | 0.03% |
| Intrepid Financial Planning Group LLC | 30,150 | $72,963 | 0.03% |
| Murchinson Ltd. | 56,250 | $136,125 | 0.02% |